Illustrative image – not actual.The facility will provide employment to more than 350 people. The company will manufacture drugs for diabetes and hypertension segments in this facility. The plant will supply to both the domestic and export markets.
The company has three plants based at Daman and Baddi, manufacturing tablets, capsules, sterile injectables and ophthalmic products, one API plant at Chiplun and biotechnology facility in Nerul, Mumbai. The company is separately investing in a new Active Pharmaceutical Ingredient (API) plant at Ambernath in Maharashtra.
